Con: are we ready to translate Alzheimer’s disease-modifying therapies to people with down syndrome?

BACKGROUND: Adults with Down syndrome develop Alzheimer’s disease neuropathology in an age-dependent manner. This unique feature provides an opportunity to test interventions targeted for prevention of Alzheimer’s disease neuropathology and dementia in Down syndrome. DISCUSSION: In considering clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Head, Elizabeth, Schmitt, Frederick A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Debate
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255531/
https://www.ncbi.nlm.nih.gov/pubmed/25478026
http://dx.doi.org/10.1186/s13195-014-0061-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255531/
https://www.ncbi.nlm.nih.gov/pubmed/25478026
http://dx.doi.org/10.1186/s13195-014-0061-6

Ejemplares similares